With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes.

Dr. Tommy Ibrahim discusses a new value-based care strategy and his plans for systemwide continuity in an exclusive interview ...

Recreational physical activity may be associated with breast tissue composition and biomarkers of stress in adolescent girls, ...

Key TakeawaysNew report shows growing use of medications, such as chemotherapy, immunotherapy, and hormone therapy, given ...

It has been one-year since the federal government has made significant changes to how scientific research proposals are ...

Cervical cancer rates are rising among millennial women, and a lack of Pap and HPV screenings are to blame, say experts.

Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is ...

Peptides are the newest kids on the block when it comes to the wellness industry. Their claimed benefits include helping you ...

The World Health Organization reports that 1 in 8 people in the world were living with obesity in 2022. In parts of the Middle East, adult obesity rates are projected to reach nearly 40% by 2030, ...

Opioid Analgesics, Addiction, Prescription Practices, Healthcare Professionals, Dakar Samba, O. , Fall, D. , Ba, I. , Ndiaye, I. , Dieye, M. , Dieye, N. and Sylla, A. (2026) Knowledge and Attitudes of ...

Aches, stiffness, and saddle pain can sneak up over time. These expert-approved fit tweaks and gear upgrades help you ride ...

Dr. Umapathy Sundaram, known as Uma to colleagues, directs research efforts that translate molecular discoveries into ...